RAP1B
Basic information
Region (hg38): 12:68610854-68671901
Links
Phenotypes
GenCC
Source:
- syndromic constitutional thrombocytopenia (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thrombocytopenia 1 with multiple congenital anomalies and dysmorphic facies | AD | Allergy/Immunology/Infectious; Cardiovascular | Some individuals have been described as being susceptible to infections, and awareness may allow early and aggressive management of infections; The condition can involve congenital cardiovascular anomalies, and awareness may allow early diagnosis and management; | Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Endocrine; Hematologic; Musculoskeletal; Neurologic; Renal | 32627184; 35451551; 37850357 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAP1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 3 | |||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | ||||
non coding | 12 | 12 | ||||
Total | 0 | 1 | 4 | 5 | 14 |
Variants in RAP1B
This is a list of pathogenic ClinVar variants found in the RAP1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-68648409-G-A | Benign (Jun 20, 2021) | |||
12-68648715-A-G | Benign (Nov 12, 2018) | |||
12-68648759-G-A | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Pathogenic (Mar 06, 2024) | ||
12-68648759-G-T | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Pathogenic (Mar 06, 2024) | ||
12-68648910-T-G | Benign (May 14, 2021) | |||
12-68650387-A-AT | RAP1B-related disorder | Likely benign (Jun 06, 2019) | ||
12-68650446-C-T | Uncertain significance (Mar 09, 2023) | |||
12-68650501-G-T | Benign (May 22, 2021) | |||
12-68650696-T-G | Benign (Jun 20, 2021) | |||
12-68652044-C-G | See cases • Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Likely pathogenic (Sep 03, 2021) | ||
12-68652046-G-A | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Pathogenic (Mar 06, 2024) | ||
12-68652046-G-C | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Pathogenic (Mar 06, 2024) | ||
12-68653883-G-A | Benign (May 14, 2021) | |||
12-68654105-A-T | Likely benign (Jul 30, 2018) | |||
12-68654111-G-A | Uncertain significance (Aug 08, 2017) | |||
12-68654177-C-T | Benign (Dec 31, 2019) | |||
12-68654201-C-T | Likely benign (Aug 07, 2018) | |||
12-68654206-T-C | Uncertain significance (Jul 26, 2022) | |||
12-68654351-T-TG | Benign (May 14, 2021) | |||
12-68654358-G-A | Benign (May 22, 2021) | |||
12-68654543-G-A | Benign (Jun 20, 2021) | |||
12-68656332-G-A | Likely benign (Jun 08, 2018) | |||
12-68656386-A-G | RAP1B-related disorder | Likely benign (Jul 30, 2019) | ||
12-68656392-A-G | Likely benign (Dec 31, 2019) | |||
12-68656419-T-C | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RAP1B | protein_coding | protein_coding | ENST00000250559 | 6 | 49754 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.910 | 0.0899 | 125456 | 0 | 1 | 125457 | 0.00000399 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.60 | 24 | 95.5 | 0.251 | 0.00000503 | 1193 |
Missense in Polyphen | 3 | 29.273 | 0.10249 | 436 | ||
Synonymous | -0.453 | 36 | 32.7 | 1.10 | 0.00000169 | 336 |
Loss of Function | 2.96 | 1 | 12.1 | 0.0823 | 5.78e-7 | 150 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000882 | 0.00000882 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.;
- Pathway
- Platelet activation - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Renal cell carcinoma - Homo sapiens (human);Long-term potentiation - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Integrin-mediated Cell Adhesion;Human Thyroid Stimulating Hormone (TSH) signaling pathway;Androgen Receptor Network in Prostate Cancer;Corticotropin-releasing hormone signaling pathway;Common Pathways Underlying Drug Addiction;Focal Adhesion;Signaling of Hepatocyte Growth Factor Receptor;MAPK Signaling Pathway;VEGFA-VEGFR2 Signaling Pathway;Chemokine signaling pathway;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;MET in type 1 papillary renal cell carcinoma;Ras Signaling;MAP2K and MAPK activation;Neutrophil degranulation;Disease;Signal Transduction;GPCR Adenosine A2A receptor;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Integrin alphaIIb beta3 signaling;HGF;Innate Immune System;Immune System;Rap1 signalling;Adaptive Immune System;MET activates RAP1 and RAC1;GPCR signaling-G alpha s Epac and ERK;Platelet Aggregation (Plug Formation);Platelet activation, signaling and aggregation;GPCR signaling-G alpha s PKA and ERK;Integrin;Integrin signaling;CXCR4-mediated signaling events;Hemostasis;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;IFN-gamma pathway;MET promotes cell motility;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Signaling by RAS mutants;Signaling by high-kinase activity BRAF mutants;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Nectin adhesion pathway;Neurotrophic factor-mediated Trk receptor signaling;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met);Signaling events mediated by focal adhesion kinase;amb2 Integrin signaling;EPHB forward signaling;PDGFR-beta signaling pathway;Trk receptor signaling mediated by the MAPK pathway;E-cadherin signaling in the nascent adherens junction
(Consensus)
Intolerance Scores
- loftool
- 0.493
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.2
Haploinsufficiency Scores
- pHI
- 0.668
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.614
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Low | Low | Low |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Rap1b
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- rap1b
- Affected structure
- endothelial cell
- Phenotype tag
- abnormal
- Phenotype quality
- absent
Gene ontology
- Biological process
- cell population proliferation;response to carbohydrate;microvillus assembly;Rap protein signal transduction;cellular response to drug;interleukin-12-mediated signaling pathway;neutrophil degranulation;establishment of endothelial barrier;positive regulation of ERK1 and ERK2 cascade;cellular response to cAMP;cellular response to gonadotropin-releasing hormone;regulation of cell junction assembly;regulation of establishment of cell polarity;negative regulation of synaptic vesicle exocytosis
- Cellular component
- lipid droplet;cytosol;plasma membrane;cell-cell junction;membrane;azurophil granule membrane;membrane raft;extracellular exosome
- Molecular function
- GTPase activity;protein binding;GTP binding;GDP binding;protein-containing complex binding